Chris Ha is Managing Partner at Avion, bringing a multidisciplinary background across biotechnology, technology, design, institutional investment, M&A, and sustainable development. A published scientist and product engineer, she has worked with organizations including Eli Lilly, aTyr Pharma, Johnson & Johnson, Pfizer, GSK, Sanofi, Merck, and UC San Diego Health, where she helped build and manage a public-private purchasing platform spanning major pharmaceutical partners. Her broader work has included product, innovation, and strategic leadership across organizations such as Stadium Goods, Luminary Media, YG Entertainment, and Sony Music, with experience spanning biotechnology, real estate, fintech, consumer technology, e-commerce, and CPG. Chris combines scientific rigor, systems thinking, technical design, and investment discipline to build commercially viable platforms, markets, and operating models. She has also contributed to sustainable development and humanitarian initiatives across Africa, Central America, Southeast Asia, and the Caribbean.